Physician profile
Zhonghui Luo
NPI 1790985935
$6,247.53
in general payments reported to CMS, 2019-2025
7 companies · $3,770 in 2025
The $3,770 reported for 2025 was more than what 92% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $1,425 · 2021: $125 · 2022: $134 · 2023: $270 · 2024: $355 · 2025: $3,770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,464 · Food and Beverage: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,464.00 |
| Food and Beverage | $931.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi US Services INC. | $3,464.00 | 2025 | |
| Alcon Research LLC | $1,425.00 | 2020 | |
| Alcon Vision LLC | $1,019.92 | 2019-2025 | Argos, Clareon, Acrysof Iq Vivity |
| Rxsight INC | $111.02 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Tarsus Pharmaceuticals, INC. | $105.60 | 2025 | |
| Oyster Point Pharma, INC. | $89.08 | 2022 | |
| Novartis Pharmaceuticals Corporation | $32.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zhonghui Luo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.